BIO-key International, Inc. BKYI
Company Overview
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.20.
Recent Developments
- Dec 2025 Revenue of $5.94M (-14.3% YoY); net profit $-7.16M.
- Trailing 12 Months Year-on-year growth — revenue +13.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 3.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.55% |
| 1 Year: | 13.10% |
Stock Price Performance
| 1 Year: | -66.20% |
| 6 Months: | -56.94% |
| 3 Months: | -35.51% |
| 1 Month: | -33.75% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)28.09 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 74.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BKYI BIO-key International, Inc. | 2.67 | -0.34 | $3.84M | 0.00% | -131.12% | -107.91% | 3.55% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 804.64K | 422.26K | 431.58K | 1.37M | 402.79K | 1.28M | 648.83K | 2.27M | 669.85K | 430.59K | 415.81K | 431.46K | 1.42M | 886.88K | 942.42K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 686.83K | 327.29K | 328.61K | 1.25M | 241.54K | 1.04M | 509.47K | 2.13M | 295.01K | 318.74K | 279.32K | 259.68K | 757.40K | 90.92K | 19.34K | -337.99K | -281.66K | -200.58K | -52.43K | 48.96K | -55.94K | 398.22K | 158.69K | 731.72K | 1.12M | 752.52K | 1.00M | 1.60M | 1.22M | 979.77K | 863.49K | 322.82K | 340.50K | 1.88M | 879.01K | 1.68M | 1.33M | 1.23M | 1.19M | 1.77M |
| Operating Income | -308.06K | -540.18K | -765.70K | -93.36K | -1.12M | -274.62K | -937.85K | 753.55K | -1.09M | -1.16M | -1.33M | -1.19M | -1.36M | -1.79M | -1.61M | -2.19M | -1.66M | -1.64M | 70 | -114.81K | -558.43K | -2.05M | -200.90K | -1.09M | -836.05K | -1.11M | -993.98K | -999.53K | -1.57M | -2.36M | -1.76M | -2.38M | -1.97M | -508.93K | -1.65M | -580.40K | -640.64K | -1.08M | -892.19K | -157.71K |
| Net Income | -315.58K | -554.83K | -782.55K | -299.21K | -1.03M | -51.53K | -924.10K | 753.15K | -1.08M | -1.16M | -1.38M | -1.13M | -1.36M | -1.79M | -1.61M | -2.19M | -1.66M | -1.64M | -1.80M | -1.43M | -1.83M | -3.37M | -1.57M | -3.29M | -851.43K | -1.16M | -1.02M | -999.40K | -1.72M | -2.40M | -1.69M | -2.48M | -1.84M | -510.29K | -1.67M | -738.96K | -736.54K | -1.17M | -964.85K | -205.04K |
| Diluted EPS | 0.00 | -0.01 | -0.01 | - | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| R&D Expense | 262.81K | 286.17K | 353.58K | 486.66K | 470.89K | 324.99K | 406.64K | 394.00K | 368.79K | 489.40K | 566.45K | 528.55K | 493.44K | 449.05K | 386.83K | 392.15K | 297.63K | 391.51K | 374.12K | 301.22K | 300.13K | 336.89K | 318.57K | 331.21K | 441.65K | 490.95K | 612.60K | 805.27K | 784.08K | 829.51K | 690.16K | 558.18K | 529.76K | 607.52K | 591.23K | 652.17K | 595.77K | 636.03K | 683.62K | 616.88K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.52M | 3.51M | 3.84M | 1.99M | 4.01M | 5.26M | 2.98M | 6.30M | 4.04M | 2.27M | 2.84M | 5.11M | 7.02M | 7.75M | 6.93M | 5.94M |
| Gross Profit | 2.96M | 2.70M | 3.26M | 1.60M | 3.26M | 3.98M | 2.25M | 3.06M | -119.65K | -193.72K | 2.04M | 3.44M | 4.58M | 1.43M | 5.64M | 4.56M |
| Operating Income | -1.20M | -1.45M | 27.89K | -2.52M | -2.04M | -1.70M | -4.20M | -4.28M | 80 | -1.07M | -5.20M | -4.94M | -9.92M | -8.83M | -4.01M | -6.83M |
| Net Income | -306.79K | -1.90M | 3.27K | -2.58M | -1.88M | -1.86M | -4.19M | -4.28M | -6.87M | -14.59M | -9.67M | -5.07M | -11.91M | -8.52M | -4.30M | -7.16M |
| R&D Expense | 1.06M | 1.12M | 947.37K | 1.34M | 1.63M | 1.56M | 2.01M | 1.66M | 1.42M | 1.33M | 1.40M | 2.36M | 3.25M | 2.39M | 2.51M | 2.61M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Jan 2018 | Dec 2018 | Jan 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 5.32M | 966.70K | 1.14M | 2.70M | 2.07M | 20.42M | 17.29M | 16.08M | 16.32M | 11.69M | 12.28M | 2.50M | 22.52M | 17.77M | 11.34M | - | - | - | 4.52M | 8.62M | 8.30M |
| Total Equity | - | 569.34K | -1.27M | -1.22M | 1.05M | 759.06K | 18.15M | 15.45M | 13.75M | 13.99M | 10.47M | - | -2.29M | 20.34M | 15.62M | 5.30M | 3.76M | 1.25M | -485.55K | 1.06M | 3.77M | 5.11M |
| Cash & Equivalents | 792.43K | 1.01M | 43.44K | 83.99K | 2.02M | 843.63K | 4.32M | 1.06M | 288.72K | - | 323.94K | - | 79.01K | 16.99M | 7.75M | 2.64M | - | - | - | 511.40K | 437.60K | 2.69M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 326.77K | - | - | - | 188.79K | 44.76K | - |
| Total Liabilities | - | 4.75M | 2.24M | 2.35M | 1.65M | 1.31M | 2.27M | 1.84M | 2.33M | - | 1.23M | 1.82M | 4.78M | 2.19M | 2.15M | 6.04M | - | - | - | 3.45M | 4.84M | 3.20M |
| Current Liabilities | - | 3.64M | 2.24M | 2.35M | 1.41M | 1.31M | 2.27M | 1.84M | 2.33M | - | 1.23M | - | 4.39M | 1.88M | 2.00M | 5.46M | - | - | - | 3.21M | 4.55M | 3.10M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -312.93K | -523.11K | 65.55K | -2.68M | -2.50M | -15.56M | -4.45M | -2.47M | -1.61M | -1.85M | -4.95M | -8.98M | -6.23M | -3.79M | -2.91M | -4.67M |
| Investing Cash Flow | 530.60K | 3.29M | - | -129.41K | -18.63K | -3.36K | -52.98K | -226.76K | -82.46K | -543.31K | -2.23M | -42.02K | -696.62K | -1.00K | -13.05K | -12.01K |
| Financing Cash Flow | - | -3.74M | -25.00K | 4.75M | 1.34M | 19.04M | 1.24M | 1.92M | 1.73M | 2.15M | 24.09M | -218.60K | 1.90M | 1.43M | 2.83M | 6.91M |
| Capital Expenditure | -9.90K | -56.20K | - | -129.41K | -18.63K | -3.36K | -52.98K | -166.06K | -52.06K | -28.75K | -35.57K | -42.02K | -82.04K | -1.00K | -13.05K | -12.01K |
| Free Cash Flow | -322.83K | -579.32K | - | -2.81M | -2.52M | -15.56M | -4.50M | -2.63M | -1.67M | -1.88M | -4.99M | -9.02M | -6.31M | -3.79M | -2.93M | -4.68M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 84.1% | 76.9% | 85.1% | 80.5% | 81.3% | 75.7% | 75.5% | 48.6% | -3.0% | -8.5% | 72.0% | 67.3% | 65.2% | 18.5% | 81.4% | 76.9% |
| Operating Margin % | -34.1% | -41.5% | 0.7% | -127.0% | -50.9% | -32.2% | -141.2% | -67.8% | 0.0% | -47.1% | -183.4% | -96.6% | -141.4% | -113.8% | -57.9% | -115.0% |
| Net Margin % | -8.7% | -54.1% | 0.1% | -130.0% | -47.0% | -35.3% | -140.8% | -67.8% | -169.8% | -643.4% | -341.0% | -99.0% | -169.7% | -109.9% | -62.1% | -120.6% |
| ROE % | -53.9% | 149.3% | -0.3% | -245.7% | -248.1% | -10.2% | -27.1% | -31.1% | -65.6% | 638.4% | -47.6% | -32.4% | -224.6% | -801.3% | -114.0% | -140.2% |
| ROCE % | -71.6% | 114.5% | -2.3% | -194.9% | -268.6% | -9.3% | -27.2% | -31.1% | 0.0% | 56.4% | -25.2% | -31.3% | -168.5% | -677.0% | -98.7% | -131.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP | 0.16% | 1.72K | $4.26K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BKYI
Shareholder vote on 1.24M new shares delayed at BIO-key (NASDAQ: BKYI) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPSW05SjItWDFid0Uza2pxaUd2U3VIcjJZcy1GNGpyTzBDMFRDQlQxRlBoUXk2dktCdncyYUVUWF92UDFfcFVtYjJ3Qkl6eWUwWXh6UzFGVzRjSzV3M19Od3RxcS1tTzhnWjBxZUVJYzhxeEpyd1NNZUFkMlFacjJrQ1pkNG1jOEZITWlHZH…
BKYI Forecast — Price Target — Prediction for 2027 - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFByaHZtSDBKQjhRVnRZc3hwUzBITW5rZGZpT2F4SlVnTGNhUHZrZm5xMktna0VMekpMNUxPQmNyMURfLWsxLUhXTVRsN2E0bFdqS0N0WG9obG5LMTZnd3doTUlBNnNhRXBlTFpseWtUblJLVUl1cUpoWmZ3?oc=5" target="_blank">BKY…
BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – BKYI Stock Gains - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOeUplZHVFNG5KTU1xSnVyekFtd0c4c2hQRGoyX3FzdG9pY0U3R2JTdkRNS2xRYm5KZFZFbTEwek1UVW5KWXVzYXk2X3hUOFRhQzNjRkQ5YzVWUVJ2YVh1U1FNMHJWNzlZcmIwZHgxMDRSUFdOVHlSOFpxekY3OVJwbnFqYWc4NXZ4TVhzbX…
BIO-KEY INTERNATIONAL ($BKYI) Releases Q1 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQN2IxakREX0F6ZVFkOUw2ZFBWZ1RrRUc2dmRBLTE2V1pWaUNXVlN4eFhuRkRqT19WX3VNTFNMNUliR1h1SGJ3ZHFaQVRwZXlQbnZzZUlucnVMZmJHZmIySUt6VWtsS3hzNC1UZ1lTQUVqcFJTMmtRbUd0bFBoQjl6QjN4WGtVMTFhVFZBST…
BKYI - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE41NmZFeGllX2pVWS0yOUM1VW1ScWh0M0JNNHFPQ3ZfZW4zdlg4bGJZTU16U3pqMG9hbFZZOE1JYlhrMnNIRnc?oc=5" target="_blank">BKYI</a> <font color="#6f6f6f">Finviz</font>…
What's Behind The Drop In BIO-Key Stock Today? - BIO-key International (NASDAQ:BKYI) - Benzinga
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOQ2JhdDFvVUhGOWtsRjBZakpoaEVIMlZ6dDc0UkR4MW9zdDg3VHprTG1Dc3B6RFZWYmZVeG5yMnA0TE5BRTMtWnN0NTNpYXk5LUdkSmhfVGkyZWhYVmgxRzFGdFNPTzhTVkNaZ0I1UktucDRZVEx0OVpPOFRsTjZoNzJIWmp6Z3BGUUMyT0…
BKYI — Frequently Asked Questions
What is the current share price of BIO-key International, Inc. (BKYI)?
As of 2026-09-19 21:16 PDT, BIO-key International, Inc. (BKYI) trades at $2.67 on NasdaqCM. Its 52-week range is $2.67 to $10.30.
What is the market capitalisation of BKYI?
BIO-key International, Inc. (BKYI) has a market capitalisation of $3.84M on NasdaqCM.
What is the P/E ratio of BKYI?
BKYI trades at a trailing price-to-earnings (P/E) ratio of -0.34. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 0.69.
What is the return on equity (ROE) of BKYI?
BKYI has a return on equity (ROE) of -107.91%. Its return on capital employed (ROCE) is -131.12%.
Is BKYI a good stock to buy?
This page provides a data-driven analysis of BIO-key International, Inc. (BKYI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.